Compare Ciputra Development Tbk (CTRA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ciputra Development Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Ciputra Development Tbk trades at Rp595 (market cap 11.31T, 6.71M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Ciputra Development Tbk is far larger — about 17.8× UBC Medical Indonesia Tbk.'s market cap, and Ciputra Development Tbk is more actively traded (6.71M versus 843K). Which is the better fit depends on your goals.
| CTRA | LABS | |
|---|---|---|
Market Cap | 11.31T | 635.95B |
Volume | 6.71M | 843K |
Lot | 67.06K | 8.43K |
Turnover | 4.02B | 137.6M |
Average Price | 598.92 | 163.22 |
Value | 4.02B | 137.6M |
Indicative Equilibrium Price | 595 | 165 |
Indicative Equilibrium Volume | 732 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ciputra Development Tbk
PT Ciputra Development Tbk (the Company) was established in the Republic of Indonesia originally under the name PT Citra Habitat Indonesia based on notarial deed No. 22 dated October 22, 1981. Ciputra Developments main interest is in residential and township developments which account for approximately 90% of the companies total sales. The company has nine flagship development projects.
Read more on CTRA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
